GlobeNewswire

Nexstim Plc publishes an EU growth prospectus regarding EUR 6.6 million subscription rights issue

Share

Company announcement, inside information, Helsinki, 8 March 2021 at 3.15 PM (EET)

Nexstim Plc publishes an EU growth prospectus regarding EUR 6.6 million subscription rights issue

Nexstim Plc (NXTMH:HEX, NXTMS:STO) (”Nexstim” or ”Company”) announces with reference to the company announcement published earlier today regarding a subscription rights issue totaling approximately EUR 6.6 million , that the Company has prepared an EU growth prospectus which the Finnish Financial Supervisory Authority (FIN-FSA) has approved on 8 March 2021. The Board of Directors of Nexstim has resolved to publish the EU growth prospectus on 8 March 2021 and it shall be notified to Sweden.

Finnish version of the EU growth Prospectus will be available approximately on 8 March 2021 on the Nexstim’s website at http://www.nexstim.com/investors/rights-issue-2021 and at the registered office of the Company at Elimäenkatu 9 B, 00510 Helsinki. Moreover, the Finnish version of the EU growth prospectus will be available at the reception of the Nasdaq Helsinki Office at Fabianinkatu 14, 00100 Helsinki.

The EU growth prospectus in English and summary in Swedish will be available on Nexstim’s website at http://www.nexstim.com/investors/rights-issue-2021 approximately on 8 March 2021.

NEXSTIM PLC

Leena Niemistö, Chair of the Board of Directors

Further information is available on the website www.nexstim.com, or by contacting:

Leena Niemistö, Chair
+358 9 2727 170
leena.niemisto@nexstim.com

Erik Penser Bank AB (Certified Adviser)                        
 +46 8 463 83 00
certifiedadviser@penser.se

About Nexstim Plc

Nexstim is a Finnish, globally operating medical technology company. Our mission is to enable personalized and effective therapies and diagnostics for challenging brain diseases and disorders.

Nexstim has developed a world-leading non-invasive brain stimulation technology called SmartFocus®. It is a navigated transcranial magnetic stimulation (nTMS) technology with highly sophisticated 3D navigation providing accurate and personalized targeting of the TMS to the specific area of the brain.

SmartFocus® technology is used in Nexstim’s proprietary Navigated Brain Therapy (NBT®) system, which is FDA cleared for marketing and commercial distribution for the treatment of major depressive disorder (MDD) in the United States. In Europe, the NBT® system is CE marked for the treatment of major depression and chronic neuropathic pain.

In addition, Nexstim is commercializing its SmartFocus® based Navigated Brain Stimulation (NBS) system for diagnostic applications. The NBS system is the only FDA cleared and CE marked navigated TMS system for pre-surgical mapping of the speech and motor cortices of the brain. Nexstim shares are listed on the Nasdaq First North Growth Market Finland and Nasdaq First North Growth Market Sweden.

For more information please visit www.nexstim.com

Attachment


About GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire

Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire

Rovio Entertainment's new team-based RPG Darkfire Heroes releases worldwide today on iOS and Android15.4.2021 15:00:00 CEST | Press release

Rovio’s new team-based RPG Darkfire Heroes releases worldwide today on iOS and Android Espoo, Finland – 15 April 2021 – Build a powerful party of heroes and embark on an adventure for the ages in Rovio Entertainment’s newest game, Darkfire Heroes. The game is available to download for free now worldwide on the App Store and Google Play after a successful soft launch period in select regions. Darkfire Heroes is a strategic team-based RPG set in a rich fantasy world. Players must assemble a powerful team of heroes to take on hordes of baddies. There is a collection of over 60 heroes at launch, each with their own unique style, abilities, and attacks. Choose the right heroes to take into battle, outfit them with powerful gear, and unleash powerful spells against enemies. There’s a substantial campaign for those looking for a single-player experience, but also a PvP arena for players that crave a bit of competition. A new IP in Rovio’s game portfolio, Darkfire Heroes is the first release f

Mid-Hudson Co-Operative Insurance Company Selects Verisk’s Sequel to Deploy Integrated Underwriting and Claims Solutions Following Migration to ISO Electronic Rating Content15.4.2021 14:00:00 CEST | Press release

JERSEY CITY, N.J., April 15, 2021 (GLOBE NEWSWIRE) -- Mid-Hudson Co-Operative Insurance Company (MHC) has selected Verisk’s Sequel to provide underwriting and claims solutions to underpin migration to ISO Electronic Rating Content™ (ERC) for rating support. New York-based MHC is a member of the National Association of Mutual Insurance Companies and provides personal, commercial and farm insurance via New York state agency Statewide Underwriting Services. Verisk’s ISO ERC solution helps insurers stay current and implement the necessary updates ISO makes to its advisory loss costs, rules and forms for a range of insurance classes and reduces the time and effort required to analyze regular ISO updates, eliminating tedious work and quickening ratings workflows. Eddie Harper President and CEO of Statewide Underwriting Services said of the agreement, “We were impressed by both the Sequel technology and expertise and the fact that Sequel is a Verisk solution was an important component in our

COVIS PHARMA GROUP Announces Top-line Safety and Efficacy Data from a Phase 3 Placebo-Controlled COVID-19 Study Using Inhaled Corticosteroid (ciclesonide)15.4.2021 13:00:00 CEST | Press release

ZUG, Switzerland, April 15, 2021 (GLOBE NEWSWIRE) -- Covis Pharma Group (the “Company”), a global specialty pharmaceutical company that markets therapeutic solutions for patients with life-threatening conditions and chronic illnesses, announced today top-line results from a 400 patient phase 3, multicenter, randomized, double-blind, placebo-controlled study to assess the safety and efficacy of ciclesonide metered-dose inhaler in non-hospitalized patients 12 years of age and older with symptomatic COVID-19 infection. The primary endpoint of the study was time to alleviation of COVID-19-related symptoms of cough, dyspnea, chills, feeling feverish, repeated shaking with chills, muscle pain, headache, sore throat, and new loss of taste or smell, defined as symptom-free for a continuous period of ≥ 24 hours by Day 30. A sub-group analysis showed that time to alleviation of cough was the most improved symptom in the ciclesonide arm compared to the placebo arm by 6 days in 75% of the populati

Talenom strengthens its business in the financial management of associations by acquiring Balance-Team Oy and raises its net sales guidance15.4.2021 12:30:00 CEST | Press release

Talenom Plc Inside information 15 April 2021 at 13:30 EEST Talenom strengthens its business in the financial management of associations by acquiring Balance-Team Oy and raises its net sales guidance Talenom Plc has acquired the Helsinki-based Balance-Team Oy, which specialises in financial management for associations. Talenom already has a business unit focused on associations and foundations, which, with the acquisition of Balance-Team Oy will make Talenom a leading provider of financial management services for nonprofit organisations in Finland. The share capital of Balance-Team Oy will be transferred to Talenom on 15 April 2021. The acquired company was formed on 1 April 2021 in a demerger in which non-accounting activities and assets were separated from the company. Net sales of the transferred accounting business for the financial year ended 31 December 2020 were 2.7 million euros (31 December 2019: 2.8 million euros) and EBITDA was 1.0 million euros (31 December 2019: 1.0 million

$125M Growth Round Fuels Keyfactor and PrimeKey Merger to Bring Machine Identity Management to the Mainstream15.4.2021 12:00:00 CEST | Press release

First-Ever Merger Between Certificate Automation and Certificate Authority Providers Set to Impact IAM Strategy for Enterprises CLEVELAND and STOCKHOLM, Sweden, April 15, 2021 (GLOBE NEWSWIRE) -- Keyfactor® and PrimeKey® today announced their intent to merge under the Keyfactor brand while committing to increased investments across all product lines. Keyfactor is the pioneer of PKI as-a-Service, and the recognized leader in certificate lifecycle automation and crypto-agility solutions. PrimeKey’s EJBCA® software offers the most powerful and flexible certificate authority (CA) supporting DevOps, IoT, manufacturing and enterprise use cases. The merger forms an industry-first machine identity management platform, combining Keyfactor’s certificate lifecycle automation with PrimeKey’s EJBCA. The new platform will provide end-to-end machine identity management – with flexible and highly scalable certificate issuance and automated deployment of machine identities across complex enterprise and

$125M i nya investeringar boostar Keyfactor och PrimeKeys fusion och mission att leverera komplett hantering av digitala identiteter15.4.2021 12:00:00 CEST | Pressemelding

Den första sammanslagningen som kombinerar certifikatshantering med -utgivning siktar på att gemensamt göra global skillnad för företags IAM-strategier CLEVELAND och STOCKHOLM, Sverige, April 15, 2021 (GLOBE NEWSWIRE) -- Keyfactor® och PrimeKey® tillkännager sin avsikt att gå samman till en företag under namnet Keyfactor, med ökade investeringar i samtliga produktlinjer. Keyfactor är pionjär inom Public Key Infrastructure (PKI) as-a-Service, och ledande inom livscykelautomatisering för digitala certifikat och lösningar inom kryptoagilitet. PrimeKeys EJBCA® är den mest kraftfulla och samtidigt mest flexibla mjukvaran inom certifikatsutgivning, så kallad Certificate Authority (CA), för DevOps, IoT, industrier samt företag. Sammanslagningen innebär marknadens första identitetshanteringsplattform för digitala identiteter och kombinerar Keyfactors livscykelautomatisering med PrimeKeys EJBCA. Den nya plattformen kommer att erbjuda en helhetslösning för hantering av digitala identiteter, med

Nexstim Abp: Kallelse till årsstämm15.4.2021 11:00:00 CEST | Pressemelding

Företagsmeddelande, Helsingfors 15 april 2021 kl. 12.00 (EEST) Nexstim Abp: Kallelse till årsstämma Nexstim Abp (NXTMH:HEX, NXTMS:STO) (”Nexstim” eller ”bolaget”) bjuder in till bolagets årsstämma den 11 maj 2021 klockan 12.00 (EEST). Årsstämman ordnas undantagsvis utan närvaro av aktieägarna eller deras ombud på Nexstims huvudkontor, Elimägatan 9 B (innergården), 4 våningen, 00510 Helsingfors. Bolagets styrelse har beslutat om undantagsarrangemangen för årsstämman med stöd av lagen om temporär avvikelse från aktiebolagslagen, som riksdagen antog den 15 september 2020. För att begränsa spridningen av pandemin med covid-19 ordnas årsstämman utan att aktieägarna eller deras ombud är fysiskt närvarande på stämman. Detta är nödvändigt för att stämman ska kunna genomföras på ett förutsebart sätt och med hänsyn till aktieägarnas, bolagets medarbetares och andra berörda parters hälsa och säkerhet. Aktieägarna och ombuden kan delta i stämman och utöva sina rättigheter endast genom att rösta på